Alerts will be sent to your verified email
Verify Email
SANJIVIN
|
Sanjivani Paranteral
|
Medico Remedies
|
Nectar Lifesciences
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
-37.68 % | 13.93 % | -0.71 % |
|
5yr Avg Net Profit Margin
|
7.02 % | 4.73 % | -0.63 % |
|
Price to Book
|
8.16 | 5.38 | 0.33 |
|
P/E
|
38.2 | 32.54 | 0.0 |
|
5yr Avg Cash Conversion Cycle
|
-55.03 Days | 53.33 Days | 81.28 Days |
|
5yr Average Interest Coverage Ratio
|
15.99 | 11.55 | 0.94 |
|
5yr Avg ROCE
|
-87.74 % | 20.03 % | 7.51 % |
|
5yr Avg Operating Profit Margin
|
9.71 % | 7.11 % | 7.57 % |
|
5 yr average Debt to Equity
|
-0.72 | 0.26 | 0.73 |
|
5yr CAGR Net Profit
|
n/a | 31.26 % | -31.15 % |
|
5yr Average Return on Assets
|
11.72 % | 6.88 % | -0.34 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
28.87 % | 62.59 % | 44.53 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 99.6 % |
|
Change in Promoter Holding (3 Yrs)
|
1.52 % | -10.75 % | -11.27 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Sanjivani Paranteral
|
Medico Remedies
|
Nectar Lifesciences
|
|---|